Development and Commercialisation Plan Sample Clauses
The Development and Commercialisation Plan clause outlines the requirements for creating, maintaining, and following a structured plan for developing and bringing a product or technology to market. Typically, this clause specifies the parties' obligations to collaborate on drafting the plan, update it regularly, and adhere to agreed milestones and timelines. For example, it may require periodic progress reports or joint review meetings to assess advancement and address challenges. Its core function is to ensure both parties are aligned in their efforts, set clear expectations, and provide a framework for accountability throughout the development and commercialisation process.
Development and Commercialisation Plan. 3.1.1 Within 90 days of the Commencement Date, the Joint Development Team shall prepare a written plan (“Development and Commercialisation Plan”) that expands upon the initial development plan set out in Schedule 3 and will describe, and provide a timeline for:
(a) all development activities for the Licensed Product in the Oncoscience Field and Territory, addressing each phase of development and the budget for completion of such activities, and providing detailed information on the activities to be conducted in the next 12 month period;
(b) intellectual property protection strategy, including applying for Orphan Drug Status, patents and supplementary protection certificates
(c) sub-licensing strategy;
(d) clinical and registration strategy, with a view to expediting regulatory approval for Licensed Product; and
(e) commercialisation strategy.
3.1.2 The Joint Development Team shall update the Development and Commercialisation Plan on a regular basis (and at least annually).